Literature DB >> 15781337

Enhanced function with decreased internalization of carboxy-terminus truncated CXCR4 responsible for WHIM syndrome.

Toshinao Kawai1, Uimook Choi, Narda L Whiting-Theobald, Gilda F Linton, Sebastian Brenner, Joan M G Sechler, Philip M Murphy, Harry L Malech.   

Abstract

OBJECTIVE: WHIM (warts, hypogammaglobulinemia, recurrent bacterial infection, myelokathexis) syndrome is an autosomal dominant immune deficiency with severe chronic neutropenia and marrow neutrophil apoptosis. Carboxy-termini truncating mutations in the chemokine receptor CXCR4 have been identified in WHIM patients. We created a retrovirus encoding mutated CXCR4 (truncating point mutation 1000C-->T [R334X] inherited heterozygously in several WHIM patients) in order to transducer healthy human CD34 stem cells and K562 to overexpress mutated CXCR4 and determined its effect on receptor responses to stromal-derived factor-1 (SDF1).
METHODS: Retrovirus vector was engineered to coexpress WHIM-associated R334X mutated CXCR4 together with green fluorescent protein (GFP). Control vectors included similar constructs with wild-type CXCR4 (WT-CXCR4) or only GFP. CD34+ cells and K562 were transduced with these vectors. Populations of 100% transduced K562 were established by sorting GFP+ cells by flow cytometry. We performed migration and calcium flux assays of transduced CD34+ cells and transduced/sorted K562. We also examined receptor recycling in response to SDF1.
RESULTS: Healthy human CD34+ cells and/or human erythroleukemia K562 cells transduced to express mutated CXCR4, WT-CXCR4, or GFP alone demonstrated that mutated CXCR4 was associated with enhanced calcium flux and enhanced migration. There was also decreased receptor internalization and enhanced recovery of surface mutated CXCR4 in response to SDF1 compared with WT-CXCR4.
CONCLUSION: We propose that decreased internalization of WHIM-associated mutated CXCR4 leads to prolongation/enhancement of signaling in response to SDF1 and that this may provide the biochemical basis for the autosomal dominant abnormalities of cell trafficking and function associated with WHIM syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15781337     DOI: 10.1016/j.exphem.2005.01.001

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  37 in total

Review 1.  Regulation of neutrophil trafficking from the bone marrow.

Authors:  Ryan B Day; Daniel C Link
Journal:  Cell Mol Life Sci       Date:  2011-11-02       Impact factor: 9.261

2.  The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome.

Authors:  David C Dale; Audrey Anna Bolyard; Merideth L Kelley; Ernest C Westrup; Vahagn Makaryan; Andrew Aprikyan; Brent Wood; Frank J Hsu
Journal:  Blood       Date:  2011-08-11       Impact factor: 22.113

3.  WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4.

Authors:  Qian Liu; Haoqian Chen; Teresa Ojode; Xiangxi Gao; Sandra Anaya-O'Brien; Nicholas A Turner; Jean Ulrick; Rosamma DeCastro; Corin Kelly; Adela R Cardones; Stuart H Gold; Eugene I Hwang; Daniel S Wechsler; Harry L Malech; Philip M Murphy; David H McDermott
Journal:  Blood       Date:  2012-05-17       Impact factor: 22.113

4.  WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncated CXCR4.

Authors:  Toshinao Kawai; Uimook Choi; Lanise Cardwell; Suk See DeRavin; Nora Naumann; Narda L Whiting-Theobald; Gilda F Linton; Jaehyun Moon; Philip M Murphy; Harry L Malech
Journal:  Blood       Date:  2006-08-31       Impact factor: 22.113

Review 5.  Regulation of CXCR4 signaling.

Authors:  John M Busillo; Jeffrey L Benovic
Journal:  Biochim Biophys Acta       Date:  2006-11-10

6.  A quadrivalent HPV vaccine induces humoral and cellular immune responses in WHIM immunodeficiency syndrome.

Authors:  Alessandra Handisurya; Christina Schellenbacher; Bärbel Reininger; Frieder Koszik; Philipp Vyhnanek; Andreas Heitger; Reinhard Kirnbauer; Elisabeth Förster-Waldl
Journal:  Vaccine       Date:  2010-05-14       Impact factor: 3.641

Review 7.  Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4.

Authors:  M P Rettig; G Ansstas; J F DiPersio
Journal:  Leukemia       Date:  2011-09-02       Impact factor: 11.528

Review 8.  WHIM syndrome: congenital immune deficiency disease.

Authors:  Toshinao Kawai; Harry L Malech
Journal:  Curr Opin Hematol       Date:  2009-01       Impact factor: 3.284

9.  An essential role of the cytoplasmic tail of CXCR4 in G-protein signaling and organogenesis.

Authors:  Darran G Cronshaw; Yuchun Nie; Janelle Waite; Yong-Rui Zou
Journal:  PLoS One       Date:  2010-11-19       Impact factor: 3.240

10.  Familial occurrence of warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome.

Authors:  Maciej Siedlar; Zbigniew Rudzki; Magdalena Strach; Elzbieta Trzyna; Anna Pituch-Noworolska; Anita Błaut-Szlósarczyk; Karolina Bukowska-Strakova; Marzena Lenart; Tomasz Grodzicki; Marek Zembala
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008-12-01       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.